A detailed history of Goldman Sachs Group Inc transactions in Natera, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 807,121 shares of NTRA stock, worth $129 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
807,121
Previous 1,001,916 19.44%
Holding current value
$129 Million
Previous $108 Million 5.45%
% of portfolio
0.02%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $19 Million - $25.3 Million
-194,795 Reduced 19.44%
807,121 $103 Million
Q2 2024

Aug 13, 2024

BUY
$85.28 - $112.6 $26.9 Million - $35.5 Million
315,676 Added 46.0%
1,001,916 $108 Million
Q1 2024

May 15, 2024

SELL
$59.21 - $92.9 $7.5 Million - $11.8 Million
-126,701 Reduced 15.59%
686,240 $62.8 Million
Q4 2023

Feb 13, 2024

BUY
$37.55 - $62.64 $9.73 Million - $16.2 Million
259,189 Added 46.81%
812,941 $50.9 Million
Q3 2023

May 14, 2024

SELL
$43.4 - $62.52 $11.2 Million - $16.2 Million
-259,189 Reduced 31.88%
553,752 $24.5 Million
Q3 2023

Nov 14, 2023

BUY
$43.4 - $62.52 $5.2 Million - $7.49 Million
119,789 Added 27.6%
553,752 $24.5 Million
Q2 2023

May 14, 2024

BUY
$47.08 - $55.16 $11.8 Million - $13.8 Million
249,684 Added 135.49%
433,963 $21.1 Million
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $11.8 Million - $13.8 Million
249,684 Added 135.49%
433,963 $21.1 Million
Q1 2023

May 14, 2024

SELL
$36.57 - $58.29 $26.6 Million - $42.4 Million
-728,067 Reduced 79.8%
184,279 $10.2 Million
Q1 2023

May 11, 2023

SELL
$36.57 - $58.29 $26.6 Million - $42.4 Million
-728,067 Reduced 79.8%
184,279 $10.2 Million
Q4 2022

May 14, 2024

BUY
$34.17 - $47.91 $3.12 Million - $4.37 Million
91,258 Added 11.11%
912,346 $36.6 Million
Q4 2022

Feb 13, 2023

BUY
$34.17 - $47.91 $3.12 Million - $4.37 Million
91,258 Added 11.11%
912,346 $36.6 Million
Q3 2022

May 14, 2024

BUY
$36.93 - $56.68 $7.64 Million - $11.7 Million
206,799 Added 33.66%
821,088 $36 Million
Q3 2022

Nov 10, 2022

BUY
$36.93 - $56.68 $7.64 Million - $11.7 Million
206,799 Added 33.66%
821,088 $36 Million
Q2 2022

May 14, 2024

SELL
$28.13 - $44.54 $5.59 Million - $8.85 Million
-198,652 Reduced 24.44%
614,289 $21.8 Million
Q2 2022

Aug 15, 2022

BUY
$28.13 - $44.54 $11 Million - $17.5 Million
392,565 Added 177.05%
614,289 $21.8 Million
Q1 2022

May 16, 2022

SELL
$30.32 - $91.33 $7.37 Million - $22.2 Million
-243,043 Reduced 52.29%
221,724 $9.02 Million
Q4 2021

Feb 14, 2022

SELL
$86.26 - $119.0 $1.93 Million - $2.67 Million
-22,428 Reduced 4.6%
464,767 $43.4 Million
Q3 2021

Nov 10, 2021

BUY
$100.17 - $126.36 $48.8 Million - $61.6 Million
487,195 New
487,195 $54.3 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.5B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.